Related Experiment Video

Updated: Dec 29, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

1.6K

NK Cell-Based Immunotherapy in Renal Cell Carcinoma

Iñigo Terrén1, Ane Orrantia1, Idoia Mikelez-Alonso1,2

  • 1Immunopathology Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain.

Cancers
|February 5, 2020
PubMed

Insights

Natural killer (NK) cells are crucial for cancer immunity. This review explores their role in kidney cancer and strategies to enhance their tumor-killing abilities for improved patient outcomes.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Natural killer (NK) cells are innate immune lymphocytes with potent anti-tumor activity.
  • NK cells are vital for tumor immunosurveillance across various cancers.
  • NK cell infiltration in renal cell carcinoma (RCC) correlates with patient survival, but their precise role remains unclear.

Purpose of the Study:

  • To review the fundamental biology and tumor-recognition mechanisms of NK cells.
  • To elucidate the specific functions of NK cells in the context of renal cell carcinoma.
  • To summarize current therapeutic strategies aimed at augmenting NK cell anti-cancer functions.

Main Methods:

  • Literature review of NK cell biology and function.
  • Analysis of studies investigating NK cells in renal cell carcinoma.
  • Synthesis of information on therapeutic approaches targeting NK cells.

Main Results:

  • NK cells possess intrinsic cytotoxic capabilities against tumor cells.
  • NK cell presence is a significant prognostic factor in renal cell carcinoma.
  • Various strategies are being developed to enhance NK cell-mediated tumor killing.

Conclusions:

  • NK cells represent a promising target for novel renal cell carcinoma therapies.
  • Further research is needed to fully understand and harness NK cell potential in kidney cancer treatment.
  • Exploiting NK cell cytotoxicity could lead to improved therapeutic outcomes for RCC patients.
Keywords:
IL-2NK cellscancer immunotherapykidney cancerrenal cell carcinomatumor microenvironment

More Related Videos

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

14.0K
Flow Cytometry-based Assay for the Monitoring of NK Cell Functions08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

21.8K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K